Abstract
Mylan Pharms. Inc. v. Merck Sharp & Dohme Corp. <i>United States Court of Appeals of the Federal Circuit, 2022 50 F.4th 147</i>
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
